Macroview Investment Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-51
| Closed | -$7.62K | – | 588 |
|
|
2024
Q1 | $7.62K | Buy |
51
+9
| +21% | +$1.35K | 0.01% | 328 |
|
|
2023
Q4 | $8.04K | Buy |
42
+36
| +600% | +$6.89K | 0.01% | 281 |
|
|
2023
Q3 | $1.06K | Buy |
+6
| New | +$1.06K | ﹤0.01% | 651 |
|
|
2019
Q4 | – | Sell |
-45
| Closed | -$4K | – | 297 |
|
|
2019
Q3 | $4K | Buy |
+45
| New | +$4K | 0.01% | 174 |
|